Nexalin Technology (NXL) Change in Account Payables (2021 - 2026)
Nexalin Technology (NXL) posted Change in Account Payables of $71349.0 for Q2 2026, up 193.29% on a QoQ basis from -$76480.0 in Q1 2026, and up 20.55% year-over-year from $59186.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Change in Account Payables (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Change in Account Payables for 6 years, with the latest figure at $71349.0 in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 20.55% year-over-year to $71349.0 in Q2 2026; TTM through Jun 2026 was -$1133.0, a 100.74% decrease from a year earlier, with the FY2025 full-year figure at $88629.0, up 2572.22% from the prior year.
- Change in Account Payables was $71349.0 for Q2 2026 at Nexalin Technology, up from -$76480.0 in the prior quarter.
- The five-year high for Change in Account Payables was $179996.0 in Q4 2025, with the low at -$353609.0 in Q1 2023.
- Average Change in Account Payables over 5 years is -$11390.4, with a median of $13895.5 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables tumbled 1819.8% in 2024, then soared 1799.2% in 2025.
- Over 5 years, Change in Account Payables stood at -$139926.0 in 2022, then soared by 162.17% to $86985.0 in 2023, then sank by 112.18% to -$10593.0 in 2024, then jumped by 1799.2% to $179996.0 in 2025, then slumped by 60.36% to $71349.0 in 2026.
- The last three Change in Account Payables figures came in at $71349.0 (Q2 2026), -$76480.0 (Q1 2026), and $179996.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 71.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 71,349.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71,349.00 |
| Mar 31, 2026 | -76,480.00 |
| Dec 31, 2025 | 179,996.00 |
| Sep 30, 2025 | -175,998.00 |
| Jun 30, 2025 | 59,186.00 |
| Mar 31, 2025 | 25,445.00 |
| Dec 31, 2024 | -10,593.00 |
| Sep 30, 2024 | 79,404.00 |
| Jun 30, 2024 | -64,372.00 |
| Mar 31, 2024 | -8,024.00 |
| Dec 31, 2023 | 86,985.00 |
| Sep 30, 2023 | 24,048.00 |
| Jun 30, 2023 | 3,743.00 |
| Mar 31, 2023 | -353,609.00 |
| Dec 31, 2022 | -139,926.00 |
| Sep 30, 2022 | -135,242.00 |
| Jun 30, 2022 | 49,675.00 |
| Mar 31, 2022 | 179,386.00 |
| Dec 31, 2021 | 137,085.00 |